Source: Eur Respir J 2015; 46: 152-164
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sitbon Olivier, Benza Raymond L., Badesch David B., Barst Robyn J., Elliott C. Gregory, Gressin Virginie, Lemarié Jean-Christophe, Miller Dave P., Muros-Le Rouzic Erwan, Simonneau Gérald, Frost Adaani E., Farber Harrison W., Humbert Marc, McGoon Michael D.. Validation of two predictive models for survival in pulmonary arterial hypertension. Eur Respir J 2015; 46: 152-164

Member's Comments

No comment yet.

Related content which might interest you: Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Improving survival in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 218-220 Year: 2005 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 A critical analysis of survival in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:218-222 Year: 2012 A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017 Pressure-flow relationship during exercise predicts transplant-free survival in patients with pre-capillary pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015 Early improvements predict outcomes in pulmonary arterial hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Predicting survival in pulmonary arterial hypertension: time to move forward Source: Eur Respir J 2010; 35: 958-959 Year: 2010 VE/VCO2 slope predicts survival in pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 250s Year: 2007 Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 704-713 Year: 2014 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Multi-omic profiling in pulmonary arterial hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018